CAS: 5027-67-8 - Benzeneacetic acid, α-[(acetyloxy)methyl]-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, hydrobromide, [7(S)-(1α,2β,4β,5α,7β)]-
Formula:C19H23NO5·BrH
InChI:InChI=1S/C19H23NO5.BrH/c1-11(21)23-10-14(12-6-4-3-5-7-12)19(22)24-13-8-15-17-18(25-17)16(9-13)20(15)2;/h3-7,13-18H,8-10H2,1-2H3;1H/t13-,14-,15-,16+,17-,18+;/m1./s1
InChI key:InChIKey=OBUFDYBDRQYWCZ-LBUMUNEBSA-N
SMILES:Br.O=C(OCC(C(=O)OC1CC2N(C)C(C1)C3OC32)C=4C=CC=CC4)C
- Synonyms:
- Benzeneacetic acid, α-[(acetyloxy)methyl]-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, hydrobromide, [7(S)-(1α,2β,4β,5α,7β)]-
- Scopolamine acetate hydrobromide
- 3-Oxa-9-azatricyclo[3.3.1.02,4]nonane, benzeneacetic acid deriv.
- (-)-Scopolamine acetate hydrobromide
- 1αH,5αH-Tropan-3α-ol, 6β,7β-epoxy-, (-)-tropate (ester) acetate, hydrobromide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
O-Acetyl Scopolamine HBr REF: 4Z-S-0129CAS: | - - - | To inquire | Mon 02 Dec 24 | |
O-Acetyl Scopolamine Hydrobromide REF: TR-A187825CAS: 5027-67-8 | - - - | 269.00 €~1,760.00 € | Wed 11 Dec 24 | |
o-Acetyl scopolamine hydrobromide REF: 3D-FAA02767CAS: 5027-67-8 | Min. 95% | To inquire | Tue 14 Jan 25 |
Ref: 4Z-S-0129
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
O-Acetyl Scopolamine Hydrobromide
Controlled ProductCAS:5027-67-8
Applications Scopolamine Hydrobromide (S200000) derivative. An acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; …
Formula:
C19H24BrNO5
Color and Shape:
Neat
Molecular weight:
426.3
Ref: TR-A187825
50mg | 269.00 € | ||
500mg | 1,760.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
o-Acetyl scopolamine hydrobromide
CAS:5027-67-8
Scopolamine is a muscarinic antagonist that is used to prevent motion sickness and the nausea …
Formula:
C19H24BrNO5
Purity:
Min. 95%
Molecular weight:
426.3 g/mol
Ref: 3D-FAA02767
250mg | To inquire | ||
500mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025